Myelodysplastic syndromes with monocytic component: Hematologic and cytogenetic characterization

Haematologica

Volumn 82, Issue 1, 1997, Pages 25-30

  Rigolin, Gian Matteo ^a   Cuneo, Antonio ^a   Roberti, Maria Grazia ^a   Bardi, Antonella ^a   Castoldi, Gianluigi ^a  

^a UNIVERSITY OF FERRARA   (Italy)

Author keywords

Chronic myelomonocytic leukemia; Monocytosis; Myelodysplastic syndromes; Myeloproliferative disorders

Indexed keywords

ADULT; AGED; ARTICLE; CHROMOSOME ANALYSIS; CHRONIC MYELOID LEUKEMIA; CHRONIC MYELOMONOCYTIC LEUKEMIA; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; HUMAN; HUMAN CELL; KARYOTYPE; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MONOCYTOSIS; MYELODYSPLASTIC SYNDROME; MYELOPROLIFERATIVE DISORDER; PRACTICE GUIDELINE; REFRACTORY ANEMIA;

CELL LINEAGE; HUMANS; INCIDENCE; LEUKEMIA, MYELOMONOCYTIC, CHRONIC; MONOCYTES; MYELODYSPLASTIC SYNDROMES; RETROSPECTIVE STUDIES; TUMOR STEM CELLS;

EID: 0031438740     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Bennett JM, Catovsky D, Daniel MT, et al. Proposals for the classification of the myelodysplastic syndromes. Br J Haematol 1982; 51:189-99.
2. Kouides PA, Bennett JM. Morphology and classification of the myelodysplastic syndromes and their pathologic variants. Semin Hematol 1996; 33:95-110.
3. Maschek H, Gutzmer R, Choritz H, Georgii A. Comparison of scoring systems in primary myelodysplastic syndromes. Am J Hematol 1995; 70:301-8.
4. Verhoef GEG, Pittaluga S, De Wolf-Peeters C, Boogaerts A. FAB classification of myelodysplastic syndromes: merits and controversies. Am J Hematol 1995; 71:3-11.
5. Catalano L, Improta S, de Laurentiis M, et al. Prognosis of chronic myelomonocytic leukemia. Haematologica 1996; 81:324-9.
6. Bennett JM, Catovsky D, Daniel MT, et al. The chronic myeloid leukemias: guidelines for distinguishing chronic granulocytic, atypical chronic myeloid and chronic myelomonocytic leukemia. Proposals by the French-American-British Cooperative Leukemia Group. Br J Haematol 1994; 87:746-54.
7. Mangi MH, Mufti GJ. Primary myelodysplastic syndromes: diagnostic and prognostic significance of immunohistochemical assessment of bone marrow biopsies. Blood 1992; 79:198-205.
8. Locatelli F, Zecca M, Pession A, Maserati E, De Stefano P, Severi F. Myelodysplastic syndromes: the pediatric point of view. Haematologica 1995; 80:268-79.
9. Tuzuner N, Cox C, Rowe J, Bennett JM. Bone marrow cellularity in myeloid stem celll disorders: impact of age correction. Leuk Res 1994; 18:559-64.
10. Tuzuner N, Cox C, Rowe JM, Watrous D, Bennett JM. Hypocellular myelodysplastic syndromes (MDS): new proposals. Br J Haematol 1995; 91:612-7.
11. Nagai K, Kohno T, Chen Y-X, et al. Diagnostic criteria for hypocellular acute leukemia: a clinical entity distinct from overt acute leukemia and myelodysplastic syndrome. Leuk Res 1996; 20:563-574.
12. Third MIC Cooperative Study Group. Recommendation for a morphologic, immunologic and cytogenetic (MIC) working classification of the primary and therapy related myelodysplastic disorders. Cancer Genet Cytogenet 1988; 32:1-10.
13. Fenaux P, Jouet JP, Zandeckel M, Lai JL, Simon M, Pollet JP, Bauters F. Chronic and subacute myelomonocytic leukaemia in the adult: a report of 60 cases with special reference to the prognostic features. Br J Haematol 1987; 65:101-6.
14. Verhoef GEG, De Wolf-Peeters C, Ferrant A, et al. Myelodysplastic syndromes with bone marrow fibrosis: a myelodysplastic disorder with proliferative features. Ann Hematol 1991; 63:235-41.
15. Ohyashiki K, Yokoyama K, Kimura Y, et al. Myelodysplastic syndromes evolving into myeloproliferative disorders: one disease or two? Leukemia 1993; 7:338-40.
16. Verhoef GEG, Demuynck H, Zacheé P, Boogaerts A. Myelodysplastic syndrome evolving into a myeloproliferative disorder one disease or two? Leukemia 1994; 8:714-5.
17. Oscier DG. Atypical chronic myeloid leukaemia, a distinct clinical entity related to the myelodysplastic syndrome? Br J Haematol 1996; 92:582-6.
18. Hochhaus A, Hehlmann R, Bartram CR, et al. and the German CML Study Group. Clinical and molecular heterogeneity of Philadelphia chromosome negative chronic myeloid leukaemia correlates with prognosis: presentation of 100 cases and division into four subgroups. Br J Haematol 1995; 89 (suppl. 1):10.
19. Cunningham I, MacCallum SJ, Nicholls MD, et al. The myelodysplastic syndromes: an analysis of prognostic factors in 226 cases from a single institution. Br J Haematol 1995; 90:602-8.
20. Rosati S, Mick R, Xu F, Stonys E, Le Beau MM, Larson R, Wardiman JW. Refractory cytopenia with multilineage dysplasia: a further characterization of an 'unclassifiable' myelodysplastic syndrome. Leukemia 1996; 10:20-6.
21. White AD, Culligan DJ, Hoy TG, Jacob A. Extended cytogenetic follow-up of patients with myelodysplastic syndrome (MDS). Br J Haematol 1992; 81:499-502.
22. Toyama K, Ohyashiki K, Koshida Y. Clinical implications of chromosomal abnormalities in 401 patients with myelodysplastic syndromes: a multicentric study in Japan. Leukemia 1993; 7:499-508.
23. Groupe Francais de Cytogénétique Hématologique (GFCH). Cytogenetic analysis in patients with primary myelodysplastic syndromes in leukaemic transformation. A report of 94 cases. Hematol Cell Ther 1996; 38:177-81.
24. Fenaux P, Morel P, Lai JL. Cytogenetics of myelodysplastic syndromes. Semin Hematol 1996; 33:127-38.
25. Hawkins JM, Moorman AV, Hoffbrand V, et al. Association of 17p loss with late-stage or refractory disease in hematologic malignancy. Cancer Genet Cytogenet 1994; 77:134-43.
26. Becher R, Carbonell F, Bartram CR. Isochromosome 17q in Ph1-negative leukemia: a clinical, cytogenetic and molecular study. Blood 1990; 75:1679-83.
27. Allen EF, Lunde JH, McNally R, Branda E. A case of acute myelofibrosis with complex karyotypic changes: a type of myelodysplastic syndrome. Cancer Genet Cytogenet 1996; 90:24-8.
28. Mikhailova N, Sessarego M, Fugazza G, et al. Cytogenetic abnormalities in patients with severe aplastic anemia. Haematologica 1996; 81:418-22.